Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.15 +0.01 (+0.88%)
At close: Sep 30, 2026 · 4:00 PM EDT

Actinium Pharmaceuticals (ATNM) Current Deferred Revenue (2021 - 2023)

Updated

Actinium Pharmaceuticals' Current Deferred Revenue was $100,000 in Q2 2023, down 50.0% from $200,000 a year earlier.

Analysis

Actinium Pharmaceuticals (ATNM) Current Deferred Revenue (2021 - 2023) Analysis & Trends

At the end of FY2021, Current Deferred Revenue at Actinium Pharmaceuticals came in at $1 million.

  • Quarterly Current Deferred Revenue has moved between $100,000 (Q1 2022) and $1 million (Q4 2021) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Actinium Pharmaceuticals 36.16 Mn 36.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 100,000.00
Sep 30, 2022 100,000.00
Jun 30, 2022 200,000.00
Mar 31, 2022 100,000.00
Dec 31, 2021 1.00 Mn
API Access

Actinium Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ATNM&period=max&api_key=YOUR_API_KEY